Credit Suisse to make capital hike decision after AGM - report
ZURICH, April 23 Credit Suisse will not decide on how it wants to raise fresh capital until after this week's annual general meeting, SonntagsZeitung reported on Sunday.
Feb 3 Portola Pharmaceuticals Inc :
* Portola Pharmaceuticals Inc - signed a $150 million royalty agreement with healthcare royalty partners
* Portola Pharma - received $50 million at closing and may receive additional $100 million upon FDA approval of andexxa for a tiered, mid-single-digit royalty
* Portola Pharmaceuticals Inc - agreement is subject to a maximum total royalty payment of 195 percent of $150 million funded by HCR
* Portola - received CRL from FDA regarding biologics license application for andexanet alfa in aug 2016; expects to resubmit application in H1 2017 Source text for Eikon: Further company coverage:
ZURICH, April 23 LafargeHolcim is close to announcing that its chief executive Eric Olsen is to step down following an internal investigation into activities at a former Lafarge cement plant in Syria, a source familiar with the matter said on Sunday.